New Treatment Lets 3 Transplant Patients Halt Anti-Rejection Drugs
The New York Times • • general
Key Points:
- Researchers at the University of Pittsburgh have trained the immune systems of some liver transplant patients to accept the organ without the need for immunosuppressive drugs.
- In the study published in Nature Communications, three of eight patients have been off anti-rejection drugs for at least three years, indicating potential long-term success.
- Experts in the field, including Dr. William Jarnagan and Dr. Joohyun Kim, praised the study as a significant step toward achieving immune tolerance in transplantation, which was once considered a distant goal.
- This approach could revolutionize transplant medicine by reducing or eliminating the need for lifelong immunosuppressive therapy, which carries significant side effects.
